Xcout Intel
KUPANDO
Kupando is a pioneering Berlin-based biopharmaceutical and biotech company headquartered in Schönefeld, Germany. The company is focused on the research and clinical development of innovative treatments to fight cancer and infectious diseases.
Subscribe to see KUPANDO’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
KUPANDO at a glance
KUPANDO is a drug discovery company headquartered in Germany. Its most recent funding round, Series A, raised $13M in September 2022. Xcout tracks 1 named person at KUPANDO, including Johanna Holldack (CEO).
KUPANDO leadership
- Johanna HolldackCEO
KUPANDO funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $13M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get KUPANDO's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on KUPANDO in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access